StockData
Korro Bio, Inc. logo

Korro Bio, Inc. (KRRO) stock

KRRONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$12.32−0.39 (-3.07%)

Close on Nov 17, 2026Market cap $181.42MP/E –Yield –

Korro Bio operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Korro Bio's operating income for the twelve months ending Jun 30, 2026 was -$110.18M. For fiscal 2025 it was -$121.86M. The highest annual figure on record is -$16.31M in fiscal 2017.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$121.86M–
FY2024Dec 31, 2024-$91.91M–
FY2023Dec 31, 2023-$84.53M–
FY2022Dec 31, 2022-$59.00M–
FY2021Dec 31, 2021-$84.03M–
FY2020Dec 31, 2020-$27.55M–
FY2019Dec 31, 2019-$20.68M–
FY2018Dec 31, 2018-$18.94M–
FY2017Dec 31, 2017-$16.31M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$20.11M–
Q1 FY2026Mar 31, 2026-$20.44M–
Q4 FY2025Dec 31, 2025-$50.40M–
Q3 FY2025Sep 30, 2025-$19.24M–
Q2 FY2025Jun 30, 2025-$27.20M–
Q1 FY2025Mar 31, 2025-$25.02M–
Q4 FY2024Dec 31, 2024-$23.04M–
Q3 FY2024Sep 30, 2024-$23.29M–
Q2 FY2024Jun 30, 2024-$24.13M–
Q1 FY2024Mar 31, 2024-$21.45M–
Q4 FY2023Dec 31, 2023-$26.89M-563.0%
Q3 FY2023Sep 30, 2023-$19.15M–
Q2 FY2023Jun 30, 2023-$18.41M–
Q1 FY2023Mar 31, 2023-$20.09M–
Q4 FY2022Dec 31, 2022$5.81M–
Q3 FY2022Sep 30, 2022-$20.28M–
Q2 FY2022Jun 30, 2022-$21.27M–
Q1 FY2022Mar 31, 2022-$23.26M–
Q4 FY2021Dec 31, 2021-$21.36M–
Q3 FY2021Sep 30, 2021-$24.99M–
Q2 FY2021Jun 30, 2021-$17.48M–
Q1 FY2021Mar 31, 2021-$20.20M–
Q4 FY2020Dec 31, 2020-$10.28M–
Q3 FY2020Sep 30, 2020-$5.42M–
Q2 FY2020Jun 30, 2020-$6.20M–
Q1 FY2020Mar 31, 2020-$5.66M–
Q4 FY2019Dec 31, 2019-$6.49M–
Q3 FY2019Sep 30, 2019-$1.25M–
Q2 FY2019Jun 30, 2019-$7.02M–
Q1 FY2019Mar 31, 2019-$5.92M–
Q4 FY2018Dec 31, 2018-$5.33M–
Q3 FY2018Sep 30, 2018-$5.06M–

More Korro Bio figures

See a number that looks wrong?